NCT02202005View on ClinicalTrials.gov

Multiple Dose BE Study With Nevirapine 400mg PR Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

July 31, 2015

Study Completion Date

August 31, 2015

Conditions
HIV-1
Interventions
DRUG

Nevirapine

Nevirapine 400mg PR tablet

DRUG

Viramune®

Viramune® 400 mg Retardtabletten

Trial Locations (1)

SW10 9TH

Chelsea and Westminster NHS Foundation Trust, London

All Listed Sponsors
lead

Ratiopharm GmbH

INDUSTRY

NCT02202005 - Multiple Dose BE Study With Nevirapine 400mg PR Tablets | Biotech Hunter | Biotech Hunter